Helicobacter pylori infection: New pathogenetic and clinical aspects

World Journal of Gastroenterology

Volumn 20, Issue 21, 2014, Pages 6386-6399

  Hagymási, Krisztina ^a   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Extraintestinal disorders; Gastroduodenal diseases; Helicobacter pylori; Host factors; Virulence factor

Indexed keywords

ADHESIN; BETA CATENIN; BETA DEFENSIN 2; CAGA PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CORTACTIN; CYTOTOXIN; EZRIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 8; LIPOCORTIN 1; LIPOCORTIN 4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN; PHOSPHOLIPASE C GAMMA; PROTEIN P53; PROTEIN ZO1; PROTEINASE ACTIVATED RECEPTOR 1; RACEMASE; SCATTER FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UVOMORULIN; VACUOLATING TOXIN; VINCULIN; VIRULENCE FACTOR;

ANAPHYLACTOID PURPURA; ARTICLE; ASTHMA; BACTERIAL CLEARANCE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; CAG REPEAT; CANCER RISK; CARDIOVASCULAR DISEASE; CHRONIC GASTRITIS; CHRONIC URTICARIA; COLORECTAL CARCINOMA; DNA POLYMORPHISM; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATOBILIARY DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; IRON DEFICIENCY ANEMIA; LARYNX CANCER; LUNG CANCER; MARGINAL ZONE LYMPHOMA; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NONHUMAN; PANCREAS CANCER; PATHOGENESIS; PEPTIC ULCER; STOMACH CARCINOMA; COLORECTAL TUMOR; COMORBIDITY; COMPLICATION; GENETICS; GENOMIC ISLAND; HEMATOLOGIC DISEASE; IMMUNE SYSTEM; INSULIN RESISTANCE; MICROBIOLOGY; PANCREAS TUMOR; PATHOPHYSIOLOGY; RISK FACTOR; SKIN DISEASE; STOMACH TUMOR; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; COLORECTAL NEOPLASMS; COMORBIDITY; GENOMIC ISLANDS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMATOLOGIC DISEASES; HUMANS; IMMUNE SYSTEM; INSULIN RESISTANCE; PANCREATIC NEOPLASMS; PEPTIC ULCER; RISK FACTORS; SKIN DISEASES; STOMACH NEOPLASMS; TREATMENT OUTCOME; VIRULENCE FACTORS;

EID: 84902084714     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i21.6386     Document Type: Article

References (137)

1. Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009; 282: 1-8 [PMID: 19111390 DOI: 10.1016/j.canlet.2008.11.016]
2. Mishra S. Is Helicobacter pylori good or bad? Eur J Clin Microbiol Infect Dis 2013; 32: 301-304 [PMID: 23132690 DOI: 10.1007/s10096-012-1773-9]
3. Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208: 233-248 [PMID: 16362989 DOI: 10.1002/path.1868]
4. Molnar B, Galamb O, Sipos F, Leiszter K, Tulassay Z. Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis 2010; 28: 604-608 [PMID: 21088410 DOI: 10.1159/000320060]
5. Yamaoka Y. Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract 2012; 2012: 371503 [PMID: 22829807 DOI: 10.1155/2012/371503]
6. Wroblewski LE, Peek RM, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010; 23: 713-739 [PMID: 20930071 DOI: 10.1128/CMR.00011-10]
7. Hatakeyama M. SagA of CagA in Helicobacter pylori pathogenesis. Curr Opin Microbiol 2008; 11: 30-37 [PMID: 18243773 DOI: 10.1016/j.mib.2007.12.003]
8. Ruggiero P. Helicobacter pylori infection: what's new. Curr Opin Infect Dis 2012; 25: 337-344 [PMID: 22555448 DOI: 10.1097/QCO.0b013e3283531f7c]
9. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777 [PMID: 7629077 DOI: 10.1074/jbc.270.30.17771]
10. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 2010; 18: 479-486 [PMID: 20863705 DOI: 10.1016/ j.tim.2010.08.003]
11. Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y, Chiba T, Fuss IJ, Kitani A, Strober W. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest 2010; 120: 1645-1662 [PMID: 20389019 DOI: 10.1172/JCI39481]
12. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006; 55: 775-781 [PMID: 16322107 DOI: 10.1136/gut.2005.083014]
13. Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T, Fukamachi H, Noda M. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 2003; 33: 375-381 [PMID: 12598897 DOI: 10.1038/ng1112]
14. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133: 926-936 [PMID: 17854597 DOI: 10.1053/ j.gastro.2007.06.056]
15. Ogiwara H, Graham DY, Yamaoka Y. vacA i-region subtyping. Gastroenterology 2008; 134: 1267; author reply 1268 [PMID: 18395110 DOI: 10.1053/j.gastro.2007.11.062]
16. Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol 2009; 47: 3493-3500 [PMID: 19726606 DOI: 10.1128/ JCM.00887-09]
17. Dossumbekova A, Prinz C, Gerhard M, Brenner L, Backert S, Kusters JG, Schmid RM, Rad R. Helicobacter pylori outer membrane proteins and gastric inflammation. Gut 2006; 55: 1360-1361; author reply 1361 [PMID: 16905702]
18. Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96: 12778-12783 [PMID: 10535999 DOI: 10.1073/pnas.96.22.12778]
19. Lin LL, Huang HC, Ogihara S, Wang JT, Wu MC, McNeil PL, Chen CN, Juan HF. Helicobacter pylori Disrupts Host Cell Membranes, Initiating a Repair Response and Cell Proliferation. Int J Mol Sci 2012; 13: 10176-10192 [PMID: 22949854 DOI: 10.3390/ijms130810176]
20. Suganuma M, Watanabe T, Yamaguchi K, Takahashi A, Fujiki H. Human gastric cancer development with TNF-α- inducing protein secreted from Helicobacter pylori. Cancer Lett 2012; 322: 133-138 [PMID: 22459353 DOI: 10.1016/ j.canlet.2012.03.027]
21. Ihan A, Pinchuk IV, Beswick EJ. Inflammation, immunity, and vaccines for Helicobacter pylori infection. Helicobacter 2012; 17 Suppl 1: 16-21 [PMID: 22958150 DOI: 10.1111/ j.1523-5378.2012.00977.x]
22. Müller A, Solnick JV. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 2011; 16 Suppl 1: 26-32 [PMID: 21896082 DOI: 10.1111/ j.1523-5378.2011.00877.x]
23. Tsai HF, Hsu PN. Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflam-mation and mucosal pathology. Cell Mol Immunol 2010; 7: 255-259 [PMID: 20190789 DOI: 10.1038/cmi.2010.2]
24. Kabir S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 2011; 16: 1-8 [PMID: 21241406 DOI: 10.1111/j.1523-5378.2010.00812.x]
25. Malfertheiner P. The intriguing relationship of Helicobacter pylori infection and acid secretion in peptic ulcer disease and gastric cancer. Dig Dis 2011; 29: 459-464 [PMID: 22095010 DOI: 10.1159/000332213]
26. Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology 2007; 132: 2320-2327 [PMID: 17570207 DOI: 10.1053/j.gastro.2007.03.108]
27. Zapata-Colindres JC, Zepeda-Gómez S, Montaño-Loza A, Vázquez-Ballesteros E, de Jesús Villalobos J, Valdovinos-Andraca F. The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease. Can J Gastroenterol 2006; 20: 277-280 [PMID: 16609757]
28. Hagymási K, Tulassay Z. [Peptic ulcer: facts and questions-2010]. Orv Hetil 2010; 151: 1054-1061 [PMID: 20558352 DOI: 10.1556/OH.2010.28892]
29. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-615 [PMID: 22575588 DOI: 10.1016/ S1470-2045(12)70137-7]
30. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789 [PMID: 11556297 DOI: 10.1056/NEJMoa001999]
31. Venkateshwari A, Krishnaveni D, Venugopal S, Shashikumar P, Vidyasagar A, Jyothy A. Helicobacter pylori infection in relation to gastric cancer progression. Indian J Cancer 2011; 48: 94-98 [PMID: 21248438 DOI: 10.4103/0019-509X.75840]
32. Pandey R, Misra V, Misra SP, Dwivedi M, Kumar A, Tiwari BK. Helicobacter pylori and gastric cancer. Asian Pac J Cancer Prev 2010; 11: 583-588 [PMID: 21039020]
33. Hu Y, Fang JY, Xiao SD. Can the incidence of gastric cancer be reduced in the new century? J Dig Dis 2013; 14: 11-15 [PMID: 23134264 DOI: 10.1111/j.1751-2980.2012.00647.x]
34. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012; 13: 2-9 [PMID: 22188910 DOI: 10.1111/ j.1751-2980.2011.00550.x]
35. Wang F, Meng W, Wang B, Qiao L. Helicobacter pyloriinduced gastric inflammation and gastric cancer. Cancer Lett 2014; 345: 196-202 [PMID: 23981572 DOI: 10.1016/ j.canlet.2013.08.016]
36. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194 [PMID: 14722144 DOI: 10.1001/ jama.291.2.187]
37. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-1540 [PMID: 15985559 DOI: 10.1136/gut.2005.072009]
38. Farinati F, Cardin R, Della Libera G, Herszenyi L, Marafin C, Molari A, Plebani M, Rugge M, Naccarato R. The role of anti-oxidants in the chemoprevention of gastric cancer. Eur J Cancer Prev 1994; 3 Suppl 2: 93-97 [PMID: 7735055 DOI: 10.1097/00008469-199412002-00017]
39. Tulassay Z, Stolte M, Engstrand L, Butruk E, Malfertheiner P, Dítê P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Herszényi L, Nagy P. Twelve-month endoscopic and histological analysis following proton-pump inhibitorbased triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol 2010; 45: 1048-1058 [PMID: 20509752 DOI: 10.3109/00365520903575737]
40. Ferreira AC, Isomoto H, Moriyama M, Fujioka T, Machado JC, Yamaoka Y. Helicobacter and gastric malignancies. Helicobacter 2008; 13 Suppl 1: 28-34 [PMID: 18783519 DOI: 10.1111/j.1523-5378.2008.00633.x]
41. Asenjo LM, Gisbert JP. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig 2007; 99: 398-404 [PMID: 17973584 DOI: 10.4321/S1130-01082007000700006]
42. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490 [PMID: 16847081 DOI: 10.1128/CMR.00054-05]
43. Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E, Tomao S, Stolte M, Morini S, Vaira D. Effects of Helicobacter pylori eradication on early stage gastric mucosa- associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105-110 [PMID: 19631287 DOI: 10.1016/ j.cgh.2009.07.017]
44. Wündisch T, Dieckhoff P, Greene B, Thiede C, Wilhelm C, Stolte M, Neubauer A. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology 2012; 143: 936-942; quiz e13-14 [PMID: 22750463 DOI: 10.1053/j.gastro.2012.06.035]
45. Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 2006; 12: 1346-1351 [PMID: 16552799 DOI: 10.3748/wjg. v12.i9.1346]
46. Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol 2012; 12: 203-213 [PMID: 22197766 DOI: 10.1016/j.meegid.2011.12.002]
47. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803 [PMID: 12454835 DOI: 10.1053/gast.2002.37043]
48. Shanks AM, El-Omar EM. Helicobacter pylori infection, host genetics and gastric cancer. J Dig Dis 2009; 10: 157-164 [PMID: 19659782 DOI: 10.1111/j.1751-2980.2009.00380.x]
49. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simões M. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-371 [PMID: 12891537 DOI: 10.1016/ S0016-5085(03)00899-0]
50. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201 [PMID: 12730860 DOI: 10.1016/S0016-5085(03)00157-4]
51. Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012; 4: 156-169 [PMID: 22844547 DOI: 10.4251/wjgo.v4.i7.156]
52. Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol 2009; 15: 2204-2213 [PMID: 19437559 DOI: 10.3748/wjg.15.2204]
53. Loh JT, Torres VJ, Cover TL. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 2007; 67: 4709-4715 [PMID: 17510398 DOI: 10.1158/0008-5472. CAN-06-4746]
54. Ek C, Whary MT, Ihrig M, Bravo LE, Correa P, Fox JG. Serologic evidence that ascaris and toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians. Helicobacter 2012; 17: 107-115 [PMID: 22404440 DOI: 10.1111/j.1523-5378.2011.00916.x]
55. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83 [PMID: 17577615 DOI: 10.1007/s10120-007-0420-0]
56. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, You WC, Gail MH. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104: 488-492 [PMID: 22271764 DOI: 10.1093/jnci/djs003]
57. Zhang ZW, Farthing MJ. The roles of vitamin C in Helicobacter pylori associated gastric carcinogenesis. Chin J Dig Dis 2005; 6: 53-58 [PMID: 15904421 DOI: 10.1111/ j.1443-9573.2005.00194.x]
58. Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, Kubo M, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y. Population- based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol 2008; 168: 1409-1415 [PMID: 18945691 DOI: 10.1093/aje/kwn276]
59. Raderer M, Wrba F, Kornek G, Maca T, Koller DY, Weinlaender G, Hejna M, Scheithauer W. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55: 16-19 [PMID: 9428370 DOI: 10.1159/000011830]
60. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez- Perez G, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001; 93: 937-941 [PMID: 11416115 DOI: 10.1093/ jnci/93.12.937]
61. Trikudanathan G, Philip A, Dasanu CA, Baker WL. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 2011; 12: 26-31 [PMID: 21206097]
62. Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis 2013; 34: 2193-2197 [PMID: 23843038 DOI: 10.1093/carcin/bgt249]
63. Jesnowski R, Isaksson B, Möhrcke C, Bertsch C, Bulajic M, Schneider-Brachert W, Klöppel G, Lowenfels AB, Maisonneuve P, Löhr JM. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology 2010; 10: 462-466 [PMID: 20720447 DOI: 10.1159/000264677]
64. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003; 95: 948-960 [PMID: 12837831 DOI: 10.1093/jnci/95.13.948]
65. Risch HA. Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol Carcinog 2012; 51: 109-118 [PMID: 22162235 DOI: 10.1002/ mc.20826]
66. Howatson AG, Carter DC. Pancreatic carcinogenesis: effect of secretin in the hamster- nitrosamine model. J Natl Cancer Inst 1987; 78: 101-105 [PMID: 3467121]
67. Annibale B, Capurso G, Delle Fave G. Consequences of Helicobacter pylori infection on the absorption of micronutrients. Dig Liver Dis 2002; 34 Suppl 2: S72-S77 [PMID: 12408446 DOI: 10.1016/S1590-8658(02)80170-0]
68. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T, Tsugane S. Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007; 12: 328-332 [PMID: 17669106 DOI: 10.1111/j.1523-5378.2007.00513.x]
69. Lin YL, Chiang JK, Lin SM, Tseng CE. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol 2010; 16: 3841-3846 [PMID: 20698048 DOI: 10.3748/wjg.v16. i30.3841]
70. Wu Q, Yang ZP, Xu P, Gao LC, Fan DM. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta-analysis. Colorectal Dis 2013; 15: e352-e364 [PMID: 23672575 DOI: 10.1111/ codi.12284]
71. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 2007; 5: 51 [PMID: 17498313 DOI: 10.1186/1477-7819-5-51]
72. Kountouras J, Kapetanakis N, Zavos C, Romiopoulos I. Impact of Helicobacter pylori infection on normal colorectal mucosa, adenomatous polyps and adenocarcinoma sequence. Colorectal Dis 2014; 16: 390-391 [PMID: 23869417 DOI: 10.1111/codi.12356]
73. Nam KW, Baeg MK, Kwon JH, Cho SH, Na SJ, Choi MG. Helicobacter pylori seropositivity is positively associated with colorectal neoplasms. Korean J Gastroenterol 2013; 61: 259-264 [PMID: 23756667 DOI: 10.4166/kjg.2013.61.5.259]
74. Visek WJ. Diet and cell growth modulation by ammonia. Am J Clin Nutr 1978; 31: S216-S220 [PMID: 707376]
75. Clinton SK, Bostwick DG, Olson LM, Mangian HJ, Visek WJ. Effects of ammonium acetate and sodium cholate on N-methyl-N'-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res 1988; 48: 3035-3039 [PMID: 3365693]
76. Cavallo P, Cianciulli A, Mitolo V, Panaro MA. Lipopolysaccharide (LPS) of helicobacter modulates cellular DNA repair systems in intestinal cells. Clin Exp Med 2011; 11: 171-179 [PMID: 21069418 DOI: 10.1007/s10238-010-0118-1]
77. Inoue I, Mukoubayashi C, Yoshimura N, Niwa T, Deguchi H, Watanabe M, Enomoto S, Maekita T, Ueda K, Iguchi M, Yanaoka K, Tamai H, Arii K, Oka M, Fujishiro M, Takeshita T, Iwane M, Mohara O, Ichinose M. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 2011; 129: 2704-2711 [PMID: 21225622 DOI: 10.1002/ijc.25931]
78. Aly A, Shulkes A, Baldwin GS. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta 2004; 1704: 1-10 [PMID: 15238241 DOI: 10.1016/j.bbcan.2004.01.004]
79. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 1472-1489 [PMID: 10995803 DOI: 10.1093/ jnci/92.18.1472]
80. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428 [PMID: 15836891 DOI: 10.1016/S0140.-6736(05)66378-7]
81. Hill MJ. Bile flow and colon cancer. Mutat Res 1990; 238: 313-320 [PMID: 2188127 DOI: 10.1016/0165.-1110(90)90023-5]
82. Xiong LJ, Tong Y, Wang ZL, Mao M. Is Helicobacter pylori infection associated with Henoch-Schonlein purpura in Chinese children? a meta-analysis. World J Pediatr 2012; 8: 301-308 [PMID: 23151856 DOI: 10.1007/s12519-012-0373-1]
83. Hernando-Harder AC, Booken N, Goerdt S, Singer MV, Harder H. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009; 19: 431-444 [PMID: 19527988 DOI: 10.1684/ejd.2009.0739]
84. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24: 1587-1600 [PMID: 19788600 DOI: 10.1111/j.1440-1746.2009.05982.x]
85. Malfertheiner P, Selgrad M, Bornschein J. Helicobacter pylori: clinical management. Curr Opin Gastroenterol 2012; 28: 608-614 [PMID: 23010682 DOI: 10.1097/MOG.0b013e32835918a7]
86. Rabelo-Gonçalves EM, Sgardioli IC, Lopes-Cendes I, Escanhoela CA, Almeida JR, Zeitune JM. Improved detection of Helicobacter pylori DNA in formalin-fixed paraffin-embedded (FFPE) tissue of patients with hepatocellular carcinoma using laser capture microdissection (LCM). Helicobacter 2013; 18: 244-245 [PMID: 23350684 DOI: 10.1111/hel.12040]
87. Esmat G, El-Bendary M, Zakarya S, Ela MA, Zalata K. Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression. J Viral Hepat 2012; 19: 473-479 [PMID: 22676359 DOI: 10.1111/j.1365-2893.2011.01567.x]
88. Tu QV, Okoli AS, Kovach Z, Mendz GL. Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp. Future Microbiol 2009; 4: 1283-1301 [PMID: 19995189 DOI: 10.2217/fmb.09.90]
89. Xuan SY, Xin YN, Chen AJ, Dong QJ, Qiang X, Li N, Zheng MH, Guan HS. Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysis. World J Gastroenterol 2008; 14: 307-312 [PMID: 18186573 DOI: 10.3748/wjg.14.307]
90. Abdel-Hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, El-Sayed M, Badr R. Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37: 1026-1033 [PMID: 17610507 DOI: 10.1111/j.1872-034X.2007.00146.x]
91. Liu X, Liang J, Li G. Lipopolysaccharide promotes adhesion and invasion of hepatoma cell lines HepG2 and HepG2.2.15. Mol Biol Rep 2010; 37: 2235-2239 [PMID: 19680784 DOI: 10.1007/s11033-009-9710-4]
92. Zhuo XL, Wang Y, Zhuo WL, Zhang XY. Possible association of Helicobacter pylori infection with laryngeal cancer risk: an evidence-based meta-analysis. Arch Med Res 2008; 39: 625-628 [PMID: 18662596 DOI: 10.1016/j.arcmed.2008.04.008]
93. Burduk PK. Association between infection of virulence cagA gene Helicobacter pylori and laryngeal squamous cell carcinoma. Med Sci Monit 2013; 19: 584-591 [PMID: 23860397 DOI: 10.12659/MSM.889011]
94. Koshiol J, Flores R, Lam TK, Taylor PR, Weinstein SJ, Virtamo J, Albanes D, Perez-Perez G, Caporaso NE, Blaser MJ. Helicobacter pylori seropositivity and risk of lung cancer. PLoS One 2012; 7: e32106 [PMID: 22384154 DOI: 10.1371/ journal.pone.0032106]
95. Deng B, Li Y, Zhang Y, Bai L, Yang P. Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis. Carcinogenesis 2013; 34: 1189-1195 [PMID: 23568955 DOI: 10.1093/carcin/bgt114]
96. Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013; 62: 1262-1269 [PMID: 23303440 DOI: 10.1136/ gutjnl-2012-303018]
97. Moss SF. The carcinogenic effect of H. pylori on the gastric epithelial cell. J Physiol Pharmacol 1999; 50: 847-856 [PMID: 10695564]
98. Zhuo WL, Zhu B, Xiang ZL, Zhuo XL, Cai L, Chen ZT. Assessment of the relationship between Helicobacter pylori and lung cancer: a meta-analysis. Arch Med Res 2009; 40: 406-410 [PMID: 19766906 DOI: 10.1016/j.arcmed.2009.05.002]
99. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 2008; 103: 3005-3010 [PMID: 19086952 DOI: 10.1111/j.1572-0241.2008.02151.x]
100. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009; 14: 144-150 [PMID: 19751440 DOI: 10.1111/j.1523-5378.2009.00705.x]
101. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and lowgrade inflammation. South Med J 2010; 103: 190-196 [PMID: 20134372 DOI: 10.1097/SMJ.0b013e3181cf373f]
102. Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004; 96: 1470-1476 [PMID: 15586651]
103. Naja F, Nasreddine L, Hwalla N, Moghames P, Shoaib H, Fatfat M, Sibai A, Gali-Muhtasib H. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012; 17: 444-451 [PMID: 23066847 DOI: 10.1111/j.1523-5378.2012.00970.x]
104. Ando T, Ishikawa T, Takagi T, Imamoto E, Kishimoto E, Okajima A, Uchiyama K, Handa O, Yagi N, Kokura S, Naito Y, Mizuno S, Asakawa A, Inui A, Yoshikawa T. Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter 2013; 18: 158-164 [PMID: 23167259 DOI: 10.1111/hel.12028]
105. Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011; 16: 79-88 [PMID: 21435084 DOI: 10.1111/j.1523-5378.2011.00822.x]
106. Albaker WI. Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact? Saudi J Gastroenterol 2011; 17: 165-169 [PMID: 21546717 DOI: 10.4103/1319-3767.80377]
107. Eshraghian A, Eshraghian H, Ranjbar Omrani G. Insulin resistance and metabolic syndrome: is Helicobacter pylori criminal? Minerva Gastroenterol Dietol 2011; 57: 379-385 [PMID: 22105726]
108. Tan HJ, Goh KL. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis 2012; 13: 342-349 [PMID: 22713083 DOI: 10.1111/ j.1751-2980.2012.00599.x]
109. Christodoulou DK, Milionis HJ, Pappa P, Katsanos KH, Sigounas D, Florentin M, Elisaf M, Tsianos EV. Association of Helicobacter pylori infection with cardiovascular disease- -is it just a myth? Eur J Intern Med 2011; 22: 191-194 [PMID: 21402252 DOI: 10.1016/j.ejim.2010.11.010]
110. Schöttker B, Adamu MA, Weck MN, Müller H, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 2012; 220: 569-574 [PMID: 22189198 DOI: 10.1016/j.atherosclerosis.2011.11.029]
111. Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011; 16 Suppl 1: 65-69 [PMID: 21896088 DOI: 10.1111/j.1523-5378.2011.00883.x]
112. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316: 1130-1132 [PMID: 9552950 DOI: 10.1136/ bmj.316.7138.1130]
113. Vahdat K, Pourbehi MR, Ostovar A, Hadavand F, Bolkheir A, Assadi M, Farrokhnia M, Nabipour I. Association of pathogen burden and hypertension: the Persian Gulf Healthy Heart Study. Am J Hypertens 2013; 26: 1140-1147 [PMID: 23744497 DOI: 10.1093/ajh/hpt083]
114. Fagoonee S, De Angelis C, Elia C, Silvano S, Oliaro E, Rizzetto M, Pellicano R. Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? Minerva Med 2010; 101: 121-125 [PMID: 20467411]
115. Yu T, Wu D, Zhao XY. Infection and eradication of Helicobacter Pylorus affecting etiology and curative effect of idiopathic thrombocytopenic purpura: a META analysis. Zhongguo Shiyanxue Yexue Zazhi 2011; 19: 1255-1259 [PMID: 22040983]
116. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006; 17: 71-77 [PMID: 16421007 DOI: 10.1080/09537100500438057]
117. Hasni SA. Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol 2012; 24: 429-434 [PMID: 22617822 DOI: 10.1097/BOR.0b013e3283542d0b]
118. Li Q, Lin X, Wu Z, He L, Wang W, Cao Q, Zhang J. Immunohistochemistry analysis of Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis. Saudi J Kidney Dis Transpl 2013; 24: 751-758 [PMID: 23816725 DOI: 10.4103/1319-2442.113871]
119. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008; 13: 323-340 [PMID: 19250507 DOI: 10.1111/ j.1523-5378.2008.00617.x]
120. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 2010; 16: 886-896 [PMID: 20143469 DOI: 10.3748/wjg.v16.i7.886]
121. Zhang ZF, Yang N, Zhao G, Zhu L, Zhu Y, Wang LX. Effect of Helicobacter pylori eradication on iron deficiency. Chin Med J (Engl) 2010; 123: 1924-1930 [PMID: 20819579]
122. Realdi G, Dore MP, Fastame L. Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 1999; 44: 229-236 [PMID: 10063905 DOI: 10.1023/ A:1026677728175]
123. Ozkasap S, Yarali N, Isik P, Bay A, Kara A, Tunc B. The role of prohepcidin in anemia due to Helicobacter pylori infection. Pediatr Hematol Oncol 2013; 30: 425-431 [PMID: 23560993 DOI: 10.3109/08880018.2013.783144]
124. Xie T, Cui X, Zheng H, Chen D, He L, Jiang B. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2013; 25: 1195-1205 [PMID: 23839160 DOI: 10.1097/MEG.0b013e328363e2c7]
125. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24 [PMID: 9207257 DOI: 10.1016/ S0016-5085(97)70075-1]
126. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588-590 [PMID: 9485003]
127. Rubenstein JH, Inadomi JM, Scheiman J, Schoenfeld P, Appelman H, Zhang M, Metko V, Kao JY. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol 2014; 12: 239-245 [PMID: 23988686]
128. Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol 2008; 86: 175-178 [PMID: 17923849 DOI: 10.1038/sj.icb.7100119]
129. Zhuo X, Zhang Y, Wang Y, Zhuo W, Zhu Y, Zhang X. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol (R Coll Radiol) 2008; 20: 757-762 [PMID: 18793831 DOI: 10.1016/j.clon.2008.07.005]
130. Wang Y, Bi Y, Zhang L, Wang C. Is Helicobacter pylori infection associated with asthma risk? A meta-analysis based on 770 cases and 785 controls. Int J Med Sci 2012; 9: 603-610 [PMID: 23028243 DOI: 10.7150/ijms.4970]
131. Wang Q, Yu C, Sun Y. The association between asthma and Helicobacter pylori: a meta-analysis. Helicobacter 2013; 18: 41-53 [PMID: 23067334 DOI: 10.1111/hel.12012]
132. Zhou X, Wu J, Zhang G. Association between Helicobacter pylori and asthma: a meta-analysis. Eur J Gastroenterol Hepatol 2013; 25: 460-468 [PMID: 23242126 DOI: 10.1097/ MEG.0b013e32835c280a]
133. Shiu J, Czinn SJ, Kobayashi KS, Sun Y, Blanchard TG. IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori. PLoS One 2013; 8: e66914 [PMID: 23776703 DOI: 10.1371/journal.pone.0066914]
134. Karimi A, Fakhimi-Derakhshan K, Imanzadeh F, Rezaei M, Cavoshzadeh Z, Maham S. Helicobacter pylori infection and pediatric asthma. Iran J Microbiol 2013; 5: 132-135 [PMID: 23825730]
135. Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg 2011; 396: 729-742 [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y]
136. Gonciarz M, Włoch M, Gonciarz Z. Helicobacter pylori in liver diseases. J Physiol Pharmacol 2006; 57 Suppl 3: 155-161 [PMID: 17033113]
137. Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters. Helicobacter 2007; 12 Suppl 1: 45-53 [PMID: 17727460 DOI: 10.1111/j.1523-5378.2007.00533.x]